Retatrutide 24mg - 10 vial kit

Retatrutide is a triple receptor agonist with activity at GLP-1, GIP, and glucagon receptors, making it mechanistically distinct from dual-agonist and single-agonist compounds in the incretin research space. Its tri-receptor profile has made it the subject of investigation across appetite signaling, glucose homeostasis, energy expenditure, and lipid metabolism pathways, with clinical-stage research producing some of the most notable body-composition data seen in this compound class to date. For researchers studying how simultaneous engagement of multiple metabolic receptor systems affects downstream signaling, retatrutide represents one of the most complex and data-rich tools currently available.

• Latest Janoshik Test Results

• Weight: .3 lbs
• Dimensions: 2 × 2 × 2 in
• MG: 12MG, 24MG, 48MG

There are no reviews yet.